Item 5.02 Departure of Directors or Certain Officers; Election of Directors;

Appointment of Certain Officers; Compensatory Arrangements of Certain

Officers.

As previously reported on the Current Report on Form 8-K (the "Original Filing") filed by Viela Bio, Inc. (the "Company") on April 30, 2020, the Company's Board of Directors (the "Board") elected Rachelle Jacques as a new director of the Company, effective as of May 1, 2020.

At the time of the Original Filing, the Board had not made a determination regarding any committee assignments for Ms. Jacques. This amended Current Report on Form 8-K is being filed to provide the committee assignment information omitted from the Original Filing. On June 19, 2020, the Board appointed Ms. Jacques to the audit committee of the Board, effective immediately.

Other than the preceding disclosure, no other disclosure reported in the Original Filing is amended pursuant to this Report.

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses